Galderma takes it steady in Japan
This article was originally published in Scrip
Executive Summary
Galdermais looking to raise its Japanese sales to the ¥10-20 billion ($108-216 million) level at reimbursement prices over the mid term, helped by new product launches, an expansion of independent marketing capability and possibly business alliances.